AMENDMENT OF LICENSE AGREEMENTLicense Agreement • March 11th, 2021 • Anixa Biosciences Inc • Pharmaceutical preparations • Pennsylvania
This Amendment of License Agreement (this “Amendment”) is made as of January 22, 2021 (the “Amendment Effective Date”), by and between The Wistar Institute of Anatomy and Biology, a nonprofit corporation organized and existing under the laws of the Commonwealth of Pennsylvania located at 3601 Spruce Street, Philadelphia, Pennsylvania 19104 (“Wistar”), and Certainty Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware with principal offices located at 3150 Almaden Expressway, Suite 250, San Jose, California 95118 (“Company”).
Redactions with respect to certain portions hereof denoted with “***” Joint Development and Option Agreement PreambleJoint Development and Option Agreement • March 11th, 2021 • Anixa Biosciences Inc • Pharmaceutical preparations • Ohio
This Joint Development and Option Agreement (“JDA”), effective and binding as of the last date of execution herein (“EFFECTIVE DATE”), is by and between The Cleveland Clinic Foundation (hereinafter referred to along with its AFFILIATEs as “CCF”), an Ohio non-profit corporation with offices located at 9500 Euclid Avenue, Cleveland, Ohio 44195; and Anixa Biosciences, Inc. (hereinafter referred to as “COMPANY”), a Delaware corporation having its principal office at 3150 Almaden Exp., Suite 250, San Jose, CA 95118.
